Sarcoma  >>  Lumakras (sotorasib)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lumakras (sotorasib) / Amgen
CodeBreak 300, NCT05198934 / 2021-004008-16: Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation

Jul 2023 - Dec 2023: Data readout from CodeBreak 300 trial for colorectal cancer
Active, not recruiting
3
160
Europe, Japan, US, RoW
Sotorasib, AMG 510, Lumakras, Lumykras, Panitumumab, Vectibix, Trifluridine and Tipiracil, Lonsurf, Regorafenib, Stivarga
Amgen
Colorectal Cancer (CRC)
03/25
03/25

Download Options